111In-DTPA-D-Phe1-octreotide binding and somatostatin receptor subtypes in thyroid tumors

scientific article (publication date: April 2000)

111In-DTPA-D-Phe1-octreotide binding and somatostatin receptor subtypes in thyroid tumors is …
instance of (P31):
scholarly articleQ13442814

External links are
P698PubMed publication ID10768564

P50authorEva Forssell-AronssonQ37369426
Ove NilssonQ42787164
Johan MölneQ42835621
Lars KölbyQ56281793
P2093author name stringAhlman H
Wängberg B
Tisell LE
Bernhardt P
Hashemi SH
Bejegård SA
P433issue4
P407language of work or nameEnglishQ1860
P304page(s)636-642
P577publication date2000-04-01
P1433published inThe Journal of Nuclear MedicineQ7743608
P1476title111In-DTPA-D-Phe1-octreotide binding and somatostatin receptor subtypes in thyroid tumors
P478volume41

Reverse relations

cites work (P2860)
Q4466114399mTc-EDDA/HYNIC-TOC and (18)F-FDG in thyroid cancer patients with negative (131)I whole-body scans.
Q44561169DOTA-NOC, a high-affinity ligand of somatostatin receptor subtypes 2, 3 and 5 for labelling with various radiometals
Q57279912Differentiated thyroid cancer theranostics: radioiodine and beyond
Q39805119Exploring new frontiers in molecular imaging: Emergence of Ga PET/CT.
Q37107084Expression of somatostatin receptor subtypes in human thyroid tumors: the immunohistochemical and molecular biology (RT-PCR) investigation
Q24657586Functional expression of the thyrotropin receptor in C cells: new insights into their involvement in the hypothalamic-pituitary-thyroid axis
Q41060321Incidentally Detected Thyroid Follicular Neoplasm on Somatostatin Receptor Imaging and Post-therapy Scan
Q44780806Indium-111 octreotide scintigraphy for the detection of non-functioning metastases from differentiated thyroid cancer: diagnostic and prognostic value
Q44443652Indium-111-Octreotide scintigraphy in differentiated thyroid carcinoma metastases that do not respond to treatment with high-dose I-131
Q38601787Indium-111-labelled octreotide scintigraphy in the diagnosis and management of non-iodine avid metastatic carcinoma of the thyroid
Q62863996Multiparametric PET imaging in thyroid malignancy characterizing tumour heterogeneity: somatostatin receptors and glucose metabolism
Q37402609Peptide receptor radionuclide therapy of treatment-refractory metastatic thyroid cancer using (90)Yttrium and (177)Lutetium labeled somatostatin analogs: toxicity, response and survival analysis
Q35750002Potential Biomarkers for Radiation-Induced Renal Toxicity following 177Lu-Octreotate Administration in Mice
Q43876300Routine preoperative (111)In-octreotide scintigraphy in patients with medullary thyroid cancer
Q31137298SSR2(a) receptor expression and adrenergic/cholinergic characteristics in differentiated SH-SY5Y cells
Q79361094Somatostatin and thyroid
Q45244510Somatostatin receptor expression in thyroid disease
Q39194102Therapeutic effect of 188Re-MAG3-depreotide on non-small cell lung cancer in vivo and in vitro.
Q35682070Utility of (99m)Tc-Hynic-TOC in 131I Whole-Body Scan Negative Thyroid Cancer Patients with Elevated Serum Thyroglobulin Levels

Search more.